The MarketWatch News Department was not involved in the creation of this content. MiniPRO(TM) - Independent Control of up to 24 Cultures for Scalable, Closed-System Cell Therapy Development CAMARILLO, ...

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

TOKYO--(BUSINESS WIRE)-- AGC Biologics, your friendly CDMO expert, will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc.’s Yokohama Technical ...

The "Cell Therapy Processing: Global Markets and Technologies" report has been added to ResearchAndMarkets.com's offering. The global market for cell therapy processing is estimated to grow from $2.7 ...

PlasmidFactory GmbH and the Fraunhofer Institute for Cell Therapy and Immunology IZI have signed a Memorandum of Understanding to combine expertise in cell therapy process development and GMP ...

ALAMEDA, Calif. and PRINCETON, N.J., May 13, 2025 /PRNewswire/ -- CellFE, a leader in microfluidics-based cell engineering, and Made Scientific, a leading cell therapy contract development and ...

As the CSO for genomic medicine at Cytiva, I have numerous interactions with our customers, and I attend many scientific and industry events. It’s great to be able to get first-hand exposure to what ...

Cell and gene therapy are revolutionary approaches to treating diseases at the molecular level. They involve the manipulation ...

CAMARILLO, Calif., Dec. 2, 2025 /PRNewswire/ -- PBS Biotech ("PBS"), a leader in single-use bioreactor technology, today announced the launch of MiniPRO™, a multi-parallel Vertical-Wheel ® bioreactor ...